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Detrimental" inflammatory" responses" in" the" central"nervous" system"are"a"hallmark"of" various"brain"
injuries"and"diseases."With"this"study"we"provide"evidence"that"lentiviral"vector=mediated"expression"
of"the"immune=modulating"cytokine"interleukin"13"(IL=13)"induces"an"alternative"activation"program"
in" both"microglia" and"macrophages" conferring" protection" against" severe" oligodendrocyte" loss" and"
demyelination" in" the" cuprizone" mouse" model" for" multiple" sclerosis" (MS)." First," IL=13" mediated"
modulation" of" cuprizone=induced" lesions" was" monitored" using" T2=weighted" magnetic" resonance"
imaging" and" magnetization" transfer" imaging," and" further" correlated" with" quantitative" histological"
analyses"for"inflammatory"cell"influx,"oligodendrocyte"death"and"demyelination."Second,"following"IL=
13" immune" gene" therapy" in" cuprizone=treated" eGFP+" bone" marrow" chimeric" mice," we" provide"

















Prinz"et"al."2011)," including"demyelinating"disorders" like"multiple"sclerosis" (MS)" (Lassmann"and"van"
Horssen"2015;"Mahad"et"al."2015;"Rawji"and"Yong"2013;"Sriram"2011)."Microglia,"well=recognized"as"
brain" tissue=specific" macrophages" (Chan" et" al." 2007;" Ginhoux" et" al." 2010;" Ginhoux" et" al." 2013;"
Tambuyzer"et"al."2009),"have"the"unique"capacity"to"sense"alterations"of"the"brain"microenvironment,"
and"in"response"rapidly"migrate,"proliferate"and"undergo"specific"differentiation"programs"in"order"to"
restore" brain" homeostasis" (Ousman" and" Kubes" 2012)." Functionally" differentiated" microglia" and"
macrophages" are" commonly" subdivided" in" two" categories" (Martinez" and"Gordon" 2014;"Mills" et" al."
2000;"Mosser"and"Edwards"2008;"Murray"et"al."2014)," the"classically"activated"phenotype,"which" is"














and" Morell" 2001;" Praet" et" al." 2014a)." In" this" study" we" applied" lentiviral" vector" (LV)=mediated"
transduction"of"the"splenium"of"the"corpus"callosum"(CC),"i.e."the"brain"area"affected"most"prominent"
in" this" neuro=inflammation"mouse"model," in" order" to" investigate" the" effect" of" IL=13"on"developing"
neuro=inflammatory" lesions" and" subsequent" demyelinating" events."While" recent" in# vivo" treatment"





addition" to" standard"T2=weighted"MRI,"we"also"utilized"magnetization" transfer" imaging" (MTI)" as" an"
emerging" technique" to" provide" greater" insight" into" the" tissue" microstructure" in" terms" of"
inflammation," gliosis" and" myelination" (Ropele" and" Fazekas" 2009)." Hence," we" here" report" on"
multiparametric" MRI" approaches" complementary" and" correlating" to" our" quantitative" histological"
analyses" for" an" accurate" in# vivo"monitoring" of" CNS" inflammatory" and" demyelinating" pathology," as"
well"as"the"effect"of"IL=13"immune"gene"therapy"thereon."Finally,"as"one"of"the"major"unsolved"issues"
in" CNS" neuro=de/regeneration" relates" to" the" specific" roles" for" CNS=resident" microglia" and" CNS=
invading"peripheral"macrophages"(London"et"al."2013)," in"our"experimental"setup"using"eGFP+"bone"














C57BL/6J=Tyrc,2J/J" mice" (albino" C57BL/6J" mice," strain" code" 000058)" and" transgenic" C57BL/6=eGFP"
mice"(strain"code"003291)"were"obtained"via"Jackson"Laboratories"and"bred"in"the"animal"facility"of"





At" the"age"of"eight"weeks,"mice" received"a" standard" rodent"chow"mixed"with"0.2%"w/w"cuprizone"





The" pCHMWS=IL=13=IRES=Pac" lentiviral" vector" (LV)" plasmid" was" constructed" by" replacing" the" eGFP"
cDNA" insert" (SpeI/XbaI" digest)" from" the" pCHMWS=eGFP=IRES=Pac" plasmid" (provided" by" the" Leuven"
viral" vector" core," Molmed," KULeuven," Belgium)" with" the" IL=13" cDNA" (NcoI/NheI" digest)" from" the"
pORF=mIL=13"plasmid"(InvivoGen)"using"standard"subcloning"techniques."The"pCHMWS=BFP=IRES=Pac"
plasmid"was" constructed"by" replacing" the"eGFP"cDNA" insert" (SpeI/XbaI"digest)" from" the"pCHMWS=
eGFP=IRES=Pac"plasmid"with"the"BFP"cDNA"(SmaI/XbaI"digest)"from"the"TagBFP"plasmid"(Evrogen)"(Le"
Blon"et"al."2014)."The"pCHMWS=IL=4=IRES=Pac"plasmid"was"constructed"by"replacing"the"eGFP"cDNA"
insert" (SpeI/XbaI" digest)" from" the" pCHMWS=eGFP=IRES=Pac" plasmid"with" the" IL=4" cDNA" (NcoI/NheI"




the" culture"medium." Expression"of" IL=13"or" IL=4"was" confirmed"by" a"murine" IL=13"or" a"murine" IL=4"
ELISA" (Peprotech)," respectively." Expression" of" the" BFP" reporter" protein" was" confirmed" by" flow"





All" surgical" interventions" were" performed" according" to" institutional" guidelines." Briefly," mice" were"
anesthetized" by" intraperitoneal" (IP)" injection" of" a" ketamine" (75"mg/kg," Anesketin;" Eurovet"
NV/SA)"+"medetomidine" (1"mg/kg," Domitor;" Pfizer" Animal"Health" S.A.)"mixture" and" positioned" in" a"






























for" excitation" and" quadrature"mouse" surface" coil" for" signal" detection." During" imaging," mice" were"
anesthetized"using"2%" isoflurane"(Isoflo®,"Abbot"Laboratories"Ltd.)" in"a"mixture"of"30%"O2"and"70%"
N2O"at"a"flow"rate"of"600"ml/min."Mice"were"fixed"in"an"animal"restrainer"with"ear"bars"and"a"tooth"















plane" resolution"=" 0.078" x" 0.078"mm," scan" time"=" 12"min"48" seconds)." For"magnetization" transfer"
contrast" (MTC)" MRI," an" off=resonance" RF" pulse" was" incorporated" into" a" RARE" T2" sequence"
(TR"="4100"ms," TE"[effective]="33.44" ms;" RARE" factor" =" 8;" NS" =" 1" with" a" slice" thickness" of" 1" mm,"
FOV"="20"×"20"mm,"matrix" size"="192"×"192," in=plane" resolution" of" 0.104" x" 0.104"mm," NA"=" 3," scan"
time" " =" 4" min" 55" seconds)." RARE" T2" images" were" acquired" without" off=resonance" RF" pulse"
(unsaturated)" and" with" off=resonance" RF" pulse" (saturated)" applied" (pulse" strength"="3"μT;" pulse"





T2" maps" were" generated" with" custom=built" programs" written" in" MATLAB" (MATLAB" R2011b," The"
MathWorks"Inc.)"using"a"monoexponential"fit"function"[y="A+C*exp"(=t/T2)],"where"A"="Absolute"bias,"
C"="signal"intensity,"T2"="transverse"relaxation"time."Regions"of"interest"(ROIs)"were"drawn"manually"
on" the" T2=weighted" images" (Figure" 1b)," according" to" a" mouse" brain" atlas," with" AMIRA" software"










All" immunofluorescence" analyses" were" performed" according" to" previously" described" procedures"
(Praet" et" al." 2014b;" Reekmans" et" al." 2013)." Mice" were" first" perfused" with" an" ice" cold" 0.9%" NaCl"
solution" followed"by" an" ice" cold" 4%"paraformaldehyde" (PFA)" solution."Next," brains"were"dissected"
and"further" fixated" in"4%"PFA"for"2h," then"dehydrated"through"a"sucrose"gradient" (2h"at"5%,"2h"at"
10%"and"overnight"at"20%)."Afterwards,"brain"tissue"was"snap=frozen"in"liquid"nitrogen"and"kept"at"=
80°C" until" further" processing." Ten" µm=thick" cryosections" were" collected" using" a" microm" cryostat."
Immunofluorescence" staining" was" performed" on" brain" slides" using" the" following" antibody"
combinations:" a" primary" chicken" anti=MBP" antibody" (Millipore," AB9348;" 1:200" dilution)" with" a"
secondary" donkey" anti=chicken" dylight" 549" antibody" (Jackson," 703=506=155," 1:1000" dilution);" a"
primary" rabbit" anti=GFAP" antibody" (Abcam," ab7779," 1:500" dilution)"with" a" secondary" donkey" anti=
rabbit" Alexa" Fluor" 555" antibody" (Invitrogen," A31572," 1:1000" dilution);" a" mouse" anti=APC/CC1"
antibody"(Calbiochem,"OP80;"1:100"dilution)"in"combination"with"a"goat"anti=mouse"Alexa"Fluor"555"
antibody" (Invitrogen," AF21425;" 1:1000" dilution);" a" primary" rat" anti=F4/80" antibody" (AbD" serotec,"
MCA497R,"1:250"dilution)"with"a"secondary"goat"anti=rat"Alexa"Fluor"555"(Invitrogen,"A21434,"1:200"
dilution);" a" primary" rabbit" anti=Iba1" antibody" (Wako," 01919741," 1:500" dilution)" with" a" secondary"
donkey" anti=rabbit" AF555" (Invitrogen," A31572," 1:1000" dilution);" a" primary" rat" anti=mouse" CD11b"
antibody" (Immunotools," 22159111," 1:200" dilution)" with" a" secondary" goat" anti=rat" Alexa" Fluor" 555"
(Invitrogen," A21434," 1:200" dilution);" a" primary" rat" anti=MHCII" antibody" (eBioscience," 14=5321=82,"
1:200"dilution)"with"a" secondary"goat" anti=rat"Alexa"Fluor"350"antibody" (Invitrogen,"A21093,"1:200"
dilution);"a"primary"rat"anti=MHCII"biotinylated"antibody"(eBioscience,"13=5321=85,"1:200"dilution)"in"
combination"with" a" streptavidin=Cy5" conjugate" (Invitrogen," SA1011," 1:50" dilution);" a" primary" goat"
anti=Arg=1" antibody" (Santa" Cruz," sc=18354," 1:50" dilution)"with" a" secondary" donkey" anti=goat" Alexa"
Fluor" 555" (Invitrogen," A21432," 1:200" dilution)" or" donkey" anti=goat" Alexa" Fluor" 350" (Invitrogen,"





research" fluorescence" microscope" (Olympus" Bx51" fluorescence" microscope)" equipped" with" an"





immunofluorescence" analysis" software" (TissueGnostics"GmbH," v3.0)," as" previously" described" by" us"
(De"Vocht"et"al."2013;"Le"Blon"et"al."2014;"Praet"et"al."2015b;"Reekmans"et"al."2013)."The"following"
parameters" were" determined:" the" cellular" density" of" F4/80+" microglia/macrophages," the" cellular"
density"of"Arg=1+"microglia/macrophages,"the"cellular"density"of"MHCII+"microglia/macrophages"and"
the" cellular" density" of" eGFP+" macrophages," Additionally," the" cellular" density" of" CC=1+"









further" processing." Total" RNA"was" extracted" using" the" Purelink" RNA"Kit" (Invitrogen)." RNA"quantity"
and" purity"were" determined" using" a"ND=1000"micro=spectrophotometer" (NanoDrop" Technologies)."
One=μg"total"RNA"was"reverse=transcribed"using"a"mixture"of" random"primers" (High"Capacity"cDNA"
Reverse" Transcription" kit," Applied" Biosystems)." PCR" primers" (provided" in" Supplementary" Table" S1)"




(Laboratorios" Conda" S.A.," Torrejon" de" Ardoz," Spain)." Real=time" quantitative" RT=PCR" analysis" was"
carried" out" using" SYBR" green" I" dye" detection" (#11761500," Invitrogen)" using" the" iCycler" iQTM"
Multicolor" Real=Time" Detection" System" (Bio=Rad," Hercules," CA," USA)." Optimized" thermal" cycling"
conditions"were:"1"min"at"50°C,"8"min"and"30"sec"at"95°C"and"40"cycles"of"15"sec"at"95°C"and"30"sec"at"
60°C." Data" were" collected" after" each" cycle" and" graphically" displayed" (iCycler" iQTM" Real=time"
Detection"System"Software,"version"3.1,"Bio=Rad)."Melt"curves"were"performed"upon"completion"of"
the" cycles" to" ensure" specificity" of" the" product" amplification."Housekeeping" gene" for" normalization"








of"cuprizone"administration,"as"described"by"the"following"equations:""Y! = Δ!! = T2!" − T2!",!Y! = Δ!"# = MTR!" −MTR!"."
with"Y1"and"Y2"defined"as"the"difference"between"the"mean"T2"relaxation"times"or"the"mean"MTR"after"
four" weeks" of" cuprizone" administration" (W4)" and" W0." For" the" EC," statistical" analyses" of" the" T2"
relaxation" times" and"MTR"were" performed" separately" on" the"mean" value" of" the" left" and" right" EC"








MHCII=" and" Arg1=expressing" F4/80" cells" was" analyzed" using" one" sample" t" test." (iii)" Comparison"
between"groups"in"cellular"density"of"eGFP+"macrophages"were"analyzed"using"generalized"estimating"
equations"(GEE),"with"the"given"p=values"being"corrected"for"multiple"testing"using"the"false"discovery"
rate" method." (iv)" The" appearance" of" MHCII=" and" Arg1=expressing" eGFP=" microglia" and" eGFP+"
macrophages"was"analyzed"using"GEE,"with" the"given"p=values"being" corrected" for"multiple" testing"
using"the"false"discovery"rate"method."(iv)"The"dependence"of"MBP"and"GFAP"coverage"percentage,"
and"cellular"density"for"CC=1+"and"F4/80+"between"T2"relaxation"times"or"MTR"was"measured"using"the"





























Before" initiating" therapeutic" experiments," correct" stereotactic" targeting"of" the" LV" injections" to" the"
splenium"was"optimised"using"the"BFP"LV"and"validated"by"means"of"histological"analysis"(Figure"1a)."




diet" (CUPRIZONE)" (Figure"2a)." This"4=week" time"point"was" chosen"as" it" corresponds" to" the"optimal"
time"window" in" the"cuprizone"mouse"model" comprising" the"highest" level"of"microglia/macrophage"
activation"with"extensive"demyelination"in"the"splenium(Praet"et"al."2014a)."In"this"part"of"the"study,"
non=invasive"MRI"was"performed"on"all"mice"prior" to" LV" injection"and/or" cuprizone"administration"
and" at" the" end" of" the" 4=week" study" period." For" analysis" of" MRI" data," regions" of" interest" were"
delineated" on" obtained" T2" and"MTR"maps" at" the" level" of" the" splenium" (Figure" 1b" upper" row)." No"












or" BFP" LV" injected" cuprizone" treated"mice" (Figures" 2b" +" 2d" and" 2c" +" 2e," CUPRIZONE" IL=13" versus"
CUPRIZONE"No" inj." and"CUPRIZONE"BFP)." Lastly,"we"noted"a" strong" inverse"correlation"between"T2"
and" MTR" values" (Figure" 2f)," implying" that" T2" and" MTR" changes" may" be" indicative" of" similar" or"










myelin" basic" protein" (MBP)" expression" in" the" splenium" (Figures" 3a" and" 3b," CONTROL" versus"
CUPRIZONE" No" inj." and" CUPRIZONE" BFP)." Additionally," significant" recruitment" of" F4/80+" activated"
microglia/macrophages" was" observed" in" mice" that" received" the" cuprizone" supplemented" diet"
without"LV"injection"or"with"injection"of"the"BFP"LV"(Figures"3c,"CONTROL"versus"CUPRIZONE"No"inj."






(Figures" 3d," CONTROL" versus" CUPRIZONE" No" inj." and" CUPRIZONE" BFP)." In" contrast," as" already"
suggested"by" the"MRI" analyses," cuprizone" treated"mice" expressing" IL=13" in" the" splenium"displayed"
significantly" higher" CC=1+" oligodendrocyte" numbers" and" less" demyelination" as" compared" to" non=
injected" or" BFP" LV" injected" cuprizone" treated" mice" (Figures" 3a" and" 3b," CUPRIZONE" IL=13" versus"
CUPRIZONE"No"inj."and"CUPRIZONE"BFP)."Interestingly,"cuprizone"treated"mice"expressing"IL=13"in"the"
splenium"also"displayed"significantly"reduced"recruitment"of"F4/80+"activated"microglia/macrophages"




conclusion" from" the" MRI" analyses," histological" data" thus" confirms" that" IL=13" LV" injection" in" the"
splenium" decreases" cuprizone" induced" inflammatory" responses" and" subsequent" oligodendrocyte"
death"and"demyelination."Furthermore,"given"the"large"dataset"obtained,"we"performed"a"correlation"
analysis" between" MRI" metrics" and" histological" metrics" at" the" level" of" the" splenium" for" all"
experimental"groups."At"one"hand,"Spearman"correlation"coefficients"revealed"an"inverse"correlation"
between"T2"values"and"the"oligodendrocyte/myelin"markers"CC=1"and"MBP"(Supplementary"Figure"S3,"
ρ" =" =0.8154" and" ρ" =" =0.7997," respectively)" and" a" positive" correlation" between" T2" values" and" the"
inflammation=associated" markers" F4/80" and" GFAP" (Supplementary" Figure" S3," ρ" =" 0.8506" and" ρ" ="











IL$13* LV* injection* in* the* splenium* protects* locally* during* cuprizone$induced* inflammation,*
oligodendrocyte*death*and*demyelination.#
Given" the"potential"of" IL=13" to" interfere"with" the"development"of" inflammatory"and"demyelinating"
events" following"cuprizone"treatment,"we"additionally" investigated"whether"the"beneficial"effect"of"
IL=13"is"restricted"to"the"LV"injection"site"(i.e."the"splenium),"or"whether"protection"can"be"observed"
at" cuprizone"affected" sites"distinct" from" the" splenium."For" this," additional" regions"of" interest"were"
delineated"on"obtained"T2"and"MTR"maps"in"the"external"capsule"at"the"level"of"the"genu"(Figure"1b,"
lower"row)."Here,"all"cuprizone"treated"mice"display"significantly"increased"T2"values"and"significantly"
decreased" MTR" values" as" compared" to" control" groups" indicating" extensive" demyelination" and"
inflammation"in"the"external"capsule"(Figures"4a"and"4b,"CONTROL"versus"CUPRIZONE)."Interestingly,"
MTR,"but"not"T2"was"able"to"detect"a"lower"deviation"of"the"normal"MTR"for"mice"that"received"the"
cuprizone"diet"and" the" IL=13"LV" injection"as"compared" to"mice" that" received"cuprizone"and"BFP"LV"
injection"or"no"injection"(Figure"4b"CUPRIZONE"IL=13"versus"CUPRIZONE"No"inj."and"CUPRIZONE"BFP)."
Further" histological" analyses," as" shown" by" the" representative" images" provided" in" figure" 4," clearly"






in" the" splenium" alters" the" response" to" cuprizone" diet," but" is" not" sufficient" to" rescue" cuprizone=
induced"pathology"in"regions"distinct"from"the"LV"injection"site."
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In"order"to"further"understand"the"observed"protective"effect"of" IL=13"LV" injection" in"the"splenium,"
we" investigated" the"expression"of"major"histocompatibility" complex"class" II" (MHCII)"and"Arginase=1"
(Arg=1)"by"activated"F4/80+"microglia/macrophages."As"already"described"above"(Figure"3c),"mice"that"
received" the" cuprizone" supplemented" diet" without" LV" injection" displayed" a" significant" increase" of"
F4/80+"microglia/macrophages"at"the"level"of"the"splenium"compared"to"control"mice"(Figures"5a"and"
5b," CUPRIZONE" No" inj." versus" CONTROL" No" inj.," BFP" LV" and" IL=13)." Interestingly," a" significant"
subpopulation"of"F4/80+"activated"microglia/macrophages" in"cuprizone"treated"mice"displays"MHCII"
expression"upon"BFP"LV"or" IL=13"LV" injection"(Figure"5a,"CUPRIZONE"No" inj."versus"CUPRIZONE"BFP"
and" IL=13)." Note" that" this" subpopulation" of" MHCII+" F4/80+" activated" microglia/macrophages" also"
significantly" appears" following" BFP" LV" injection" in" control" mice" (Figure" 5a," CONTROL" BFP)."
Furthermore,"a" significant" subpopulation"of"F4/80+"activated"microglia/macrophages"displays"Arg=1"
expression"upon"IL=13"LV"injection"only"in"cuprizone"treated"mice"(Figure"5b"CUPRIZONE"IL=13"versus"
CUPRIZONE" No" inj." and" BFP)." Next," we" investigated" whether" the" observed" F4/80+MHCII+" and"
F4/80+Arg=1+"cells"are" independent"cell"populations"or"whether"they"are"the"same"cell"population."
Interestingly,"upon"co=staining"of"MHCII"and"Arg=1,"it"is"clear"that"cuprizone"treated"mice"expressing"
IL=13" present" three" distinct" populations" of" cells" which" either" are"MHCII+," Arg=1+" or" Arg=1+=MHCII+,"
with"the" latter"two"being"the"most"prominent" (Figure"5c,"CUPRIZONE"IL=13)."Summarizing,"we"here"
demonstrate"that"LV"injection,"either"BFP"LV"or"IL=13"LV,"can"modulate"the"activation"state"of"F4/80+"
activated" microglia/macrophages" as" demonstrated" by" the" expression" of" MHCII." Additionally,"
expression" of" IL=13" was" able" to" induce" Arg=1" expression" in" activated" F4/80+" and" F4/80+MHCII+"








in" cuprizone" treated" mice," we" determined" the" mRNA" expression" levels" of" multiple" cytokines" and"
immune"phenotype"markers"at"the"level"of"the"CC"in"different"experimental"groups"by"means"of"qRT=
PCR." At" first," it" is" clear" that" mRNAs" encoding" Arg=1," YM=1" and" Gal=3," which" are" associated" with"
alternative"microglia/macrophage"activation,"are"significantly"up=regulated"in"cuprizone"treated"mice"
injected" with" IL=13" LV," as" compared" to" healthy" control" and" non=injected" cuprizone" treated" mice"
(Figures" 6a," 6b" and" 6c)." While" the" pro=inflammatory" cytokines" TNF=α," IL=1β" and" iNOS" were"
significantly"up=regulated" in"cuprizone" treated"mice" injected"with" the"BFP"LV"mice,"but"not" in"non=
injected" cuprizone" treated" mice," cuprizone" treated" mice" injected" with" IL=13" LV" were" able" to"
counteract"TNF=α,"but"not"IL=1β"expression"(Figures"6d,"6e"and"6f)."Unexpectedly,"a"small"increase"of"
iNOS"mRNA"was"detected" in" cuprizone" treated"mice" injected"with" IL=13" LV" (Figure"6f)."Concluding,"
our" results" demonstrate" that" in" vivo" LV" mediated" IL=13" expression" is" capable" to" induce" mRNA"
expression"associated"with"alternative"microglia/macrophage"activation,"which"might"lie"at"the"basis"







As" the" initiation" and" modulation" of" neuro=inflammation" is" a" complex" interplay" between" brain"
resident"microglia"and"peripheral" immune"cells,"we"here" investigated"whether"any"of" the"observed"







weighted" imaging" (Figure" 7b)." In" agreement" with" the" above=described" results," MHCII+" cells" were"
detected"in"both"BFP"LV"and"IL=13"LV"injected"mice,"while"Arg=1+"cells"were"only"detected"in"IL=13"LV"
injected"mice" (Figure" 7c," second" +" third" column)." Based" on" eGFP" expression," which" discriminates"
infiltrating"eGFP+"peripheral"macrophages"from"brain"resident"eGFP="microglia,"it"can"be"noted"that"a"
significantly"higher"number"of"eGFP+"peripheral"macrophages"contributes"to"="or"at"least"are"present"="
within" cuprizone" induced" inflammatory" lesions" in" the" splenium" upon" BFP" LV" or" IL=13" LV" injection"
(Figure" 7c," first" column;" Figure" 7d," No" inj." versus" BFP" and" IL=13)." Further" co=localisation" studies"
revealed"that"MHCII"is"expressed"by"both"eGFP+"macrophages"and"eGFP="microglia"upon"control"BFP"
LV" (Figure" 7c," fourth" column"middle" image;" Figure" 7e," BFP)." Similarly" =" and"highly" interesting" =" co=
localisation" studies" reveal" that" expression" of" IL=13" in" the" splenium" by" means" of" LV" injection" and"
subsequent"cuprizone"administration" leads"to"the"significant"appearance"of"4"distinct" inflammatory"
cell" populations:" MHCII+," Arg=1+" and" Arg=1+MHCII+" eGFP+" macrophages" and" Arg=1+MHCII+" eGFP="
microglia" (Figure" 7c," fourth" column" lower" image;" Figure" 7e," IL=13)." These" data" indicate" that" both"
infiltrating"macrophages"and"brain=resident"microglia"have"the"capacity"to"display"Arg=1"expression"in"
vivo" upon" stimulation" with" IL=13," and" thereby" potentially" contribute" to" the" beneficial" effects"
observed"on"inflammation"and"demyelination."""
"




of" 2.5" weeks" in" order" to" trigger" a" neuro=inflammatory" response" and" oligodendrocyte" metabolic"
impairment."After"2.5"weeks"of"cuprizone"treatment,"mice"received"an"injection"of"the"IL=13"LV"and"





only"MTR"revealed"a"significantly" lower"deviation"of"the"normal"MTR" in" IL=13"LV" injected"cuprizone"
treated" mice" as" compared" to" non=injected" cuprizone" treated" mice" (Figures" 8b," 8c" and" 8d)."
Histological"analyses"confirmed"the"presence"of"oligodendrocytes"and"myelin"(Figure"8e,"left"panels)"
in" cuprizone" treated" mice" that" received" the" IL=13" LV" injection." Importantly," and" in" line" with" the"
findings" reported" above," this" neuro=protection" was" associated" with" the" presence" Arginase1" and"
MHCII" expressing" microglia" and" macrophages" (Figure" 8e," right" panels)." In" summary," our" results"
suggest" that" LV"mediated" expression" of" IL=13" in" a" pre=existing" neuro=inflammatory" environment" is"







Halting" the" progression" of" brain" damage" while" preventing" and" limiting" further" pathological"
alterations"are"critical"steps"for"the"treatment"of"progressive"neurodegenerative"diseases"such"as"MS"
(Giunti" et" al." 2014;" Goldmann" and" Prinz" 2013;" van" Noort" et" al." 2011)." In" this" study," we" used" the"
cuprizone" mouse" model" of" MS" to" induce" highly" inflammatory" demyelinating" lesions" in" the" white"
matter"(Gudi"et"al."2014;"Gudi"et"al."2009;"Orije"et"al."2015;"Remington"et"al."2007;"Steelman"et"al."
2012)" and" subsequently" demonstrate" that" targeted" delivery" of" IL=13" to" the" lesion" site," prior" and"
during" lesion" induction," induced" the" expression" of"markers" characteristic" for" alternative" activation"
both"in"microglia"and"macrophages."The"latter"is"here"shown"to"be"associated"with"a"protective"effect"
on" oligodendrocyte" survival" and" subsequently" less" severe" demyelination" during" cuprizone"
administration." These" results" are" fully" in" line" with" current" understandings" of" neuro=inflammatory"
processes"in"health"and"disease"(Cherry"et"al."2014;"Murray"et"al."2014;"Rawji"and"Yong"2013),"which"
suggest" that" modulating," rather" than" suppressing," microglial" activation" may" be" a" more" adequate"
therapeutic"approach"(David"and"Kroner"2011;"Tang"and"Le"2015)."Because"microglia"share"functional"
similarities" with" peripheral" macrophages," microglial" activation" and" polarization" state" is" generally"
classified"using"the"established"macrophage’s"nomenclature,"i.e."classically"activated,"also"referred"as"
M1=like" phenotype," or" alternatively" activated," also" referred" as" M2=like" phenotype," which" in" turn"
comprises"several"subtypes"of"cell"activation"(David"and"Kroner"2011;"Hu"et"al."2012)."In"the"present"
study,"we" report" on" the" in# vivo" induction" of" arginase1" expressing" alternatively" activated"microglia"
and"macrophages"following"LV"mediated"delivery"of"IL=13,"similar"to"IL=4"a"well"described"inducer"of"
this" specific" subset" of" alternatively" activated" microglia" and" macrophages" (Franco" and" Fernandez=
Suarez" 2015;"Orihuela" et" al." 2015)."Of" note," although" not" described" in" detail" in" this"manuscript," a"
similar" set" of" experiments" using" an" IL=4" encoding" LV" also" demonstrates" similar" protection" against"
demyelination"upon"injection"into"the"splenium"of"cuprizone"treated"mice"(Supplementary"Figure"S5"




induced" pathology." The" latter" may" not" be" unexpected" as" IL=4" and" IL=13" share" common" receptor"
components" (Kelly=Welch" et" al." 2003;" Van" Dyken" and" Locksley" 2013)," but" may" display" divergent"
effects" on"microglia" and"macrophages."While"macrophages" generally" are"directed" towards" the"M2"
activation" state" (Dhakal" et" al." 2014;" Murray" et" al." 2014;" Orihuela" et" al." 2015)," microglia" may"







as" liposomes" or" nanoparticles" containing" the" selected" compound" (Malam" et" al." 2009)," direct"
engraftment"of"engineered"cells"producing"the"protein"of"interest"(Stuckey"and"Shah"2014;"Tan"et"al."
2005)," or" gene" transfer" using" altered" machinery" of" viruses" (Houghton" et" al." 2015)." Following" our"
approach" using" LV" injections" in" brains" of" healthy" and" cuprizone" treated" mice," several" interesting"
observations" were"made." As" observed" on" Figure" 3," LV" injections" resulted" in" a" slight" activation" of"
microglia"and"macrophages"(Figure"3c,"F4/80)"and"upregulation"of"MHCII"expression"in"case"of"BFP"LV"
injections"in"control"mice"(Figures"5a"and"5c,"MHCII),"most"likely"illustrating"the"response"to"the"viral"
particles" and" the" attempt" to"eliminate" them."Remarkably," in" case"of" cuprizone" administration," the"
vast" majority" of" microglia" and" infiltrating" macrophages" at" the" level" of" the" LV" injection" showed"
upregulation"of"MHCII,"both"in"case"of"BFP"or"IL=13"LV"injections"(Figures"5,"7c,"7e"and"8e),"while"only"
very"little"MHCII"expression"was"observed"in"case"of"cuprizone"treated"mice"that"did"not"received"a"
LV" injection." These" alterations" in" the" pro=inflammatory" phenotype" following" cuprizone"




mRNA" (Figures" 6e" and" 6f)." These" results" are" in" line" with" previous" studies" showing" that" LV"
transduction" can" elicit" a" transient" pro=inflammatory" response" against" the" LV" particles" (Kay" 2011),"
mediated" by" the" activation" of" toll=like" receptor" 7" and" or" toll=like" receptor" 9," which" respectively"
recognize" single" stranded" RNA" and" unmethylated" CpG" (Matrai" et" al." 2010)." Consequently," the"
exacerbated"immune"response"observed"following"cuprizone"administration"in"BFP"LV"injected"mice"
can" be" explained" by" a" possible" priming" effect" of" innate" immune" cells" following" lentiviral" vector"
infection"and/or"by"the"high"infiltration"of"peripheral"macrophages,"caused"by"a"blood"brain"barrier"
breakdown" at" the"moment" of" the" intracerebral" surgery" (Figure" 7d)," thereby"modifying" the" lesion"
environment"as" compared" to"mice" that"did"not" received"a" LV" injection" (no"mechanical"blood=brain"
barrier" damage" and" limited" recruitment" of" peripheral"macrophages)." Likewise,"we" cannot" exclude"
that"priming"of"innate"immune"cells"following"lentiviral"vector"infection"may"be"the"key"to"successful"
IL=13" mediated" deviation" from" classically" activated" towards" alternatively" activated" microglia" and"
macrophages," the" latter"upregulating," next" to"MHCII" (Zurawski" and"de"Vries" 1994)," also" arginase1,"
YM=1"and"galectin=3"(Figure"5b"and"5c,"Figure"6"a=c,"Figure"7c"and"7e,"Figure"8e),"which"we"associate"
with" the" beneficial" effect" on" oligodendrocyte" survival" and"myelin" preservation." Interestingly," IL=13"
was"also"able"to"counteract"the"upregulation"of"TNF=α"mRNA"as"a"consequence"of"LV"injection."This"is"
highly"interesting"in"view"of"the"observation"that"in"TNF=α"knock=out"mice"cuprizone"administration"
results" in"a"higher"survival"of"oligodendrocytes"and"preservation"of"myelin"up" to"4"weeks"after" the"
start" of" the" cuprizone"diet" (Arnett" et" al." 2001)." Furthermore," our" observations" that" IL=13" (and" IL=4"
immune" gene" therapy," Supplementary" Figure" S5" and" Supplementary" Table" S17)" is" able" to" exert"
beneficial" effects" on" neuro=inflammation" and" demyelination" in" the" cuprizone"mouse"model" is" also"
further" supported"by" a" recent" publication"by" Janssens" et" al." showing" that" LV"mediated"delivery" of"
oncostatin" M" (OSM)" can" induce" alternatively" activated" microglia" and" macrophages" via" the"






on" inflammation" and" demyelination," an" important" aspect" that" still" remains" to" be" elucidated" is"
whether"alternatively"activated"microglia"and"macrophages"stimulated"by"the"addition"of"IL=13"would"
play"a"beneficial"role"in"the"repair"process"and"remyelination"once"cuprizone"administration"is"halted."
While" in" our" hands" no" classical" M1=" or" M2=associated" phenotypic" markers" can" be" found" in" the"
cuprizone" model," a" few" studies" have" shown" that" microglia" and" macrophages" display" a" distinct"
phenotype"supportive"of"remyelination"(Gudi"et"al."2011;"Morell"et"al."1998;"Olah"et"al."2012;"Voss"et"
al." 2012)." Along" with" the" secretion" of" anti=inflammatory" factors," growth" factors" and" neurotrophic"
factors,"there" is"accumulating"evidence"that"phagocytosis"of"myelin"debris" is"an"essential"step"for"a"
successful"remyelination"and"that"this"step" is"ensured"by"alternatively"activated"polarized"microglia"
and" macrophages" (Cantoni" et" al." 2015;" Lampron" et" al." 2015;" Poliani" et" al." 2015;" Skripuletz" et" al."






studies" allowing" discrimination" between" both" cell" populations." Especially" for" the" cuprizone"mouse"






found" that" both" populations" displayed" an" alternatively" activated" phenotype" (Figure" 7c" and" 7e)."
Recently" it" has" however" been" clearly" shown" that" radiation" bone"marrow" chimeric"mice" display" an"
27"
"
altered" BBB" permeability" to" systemic" monocytes(Morganti" et" al." 2014)," suggesting" that" certain"
results" need" caution" during" interpretation" as" the" function" and" recruitment" of" peripheral"
macrophages"may"slightly"differ"from"non=irradiated"non=injected"animals."Nevertheless,"our"results"
were" already" able" to" demonstrate" that" IL=13" act" on" both" microglia" and" infiltrating" macrophages,"





and" monitoring" of" demyelinating" lesions" over" time" in" patients" suffering" from" MS" (Polman" et" al."




to" the" brain" microstructure" and" underlying" histopathological" events" following" cuprizone"





values" while" other" studies" followed" cuprizone" induced" changes" over" time," hence" enabling" to"
differentiate"between"sequential"cellular"events."Additionally,"we"here"demonstrate"that"both"T2"and"
MTR" measures" are" suitable" to" detect" alterations" in" neuro=inflammation" and" associated"






MTI"measurements"with" quantitative" histological" analyses," the"multimodal" character" or" this" study"
clearly"contributes"to"the"validity"of"the"observed"therapeutic"effect"of"IL=13"immune"gene"therapy.""
In" conclusion," the" results" presented" in" this" study" reveal" a" neuroprotective" role" of" IL=13" in"
demyelinating" lesions" through" the" induction" of" alternatively" activated"microglia" and"macrophages."
The" ability" of" IL=13" to" trigger" the" switch" from" a" pro=inflammatory" environment" towards" an" anti=
inflammatory" environment," and" thus" limit" CNS=induced" pathology," is" of" particular" interest" for" the"
design" of" new" drug" based" therapies" aiming" at" modulating" microglial" function" to" preserve" tissue"
homeostasis"and"support" remyelination" in"MS"and"other"demyelinating"diseases." In"addition," these"
findings" emphasize" the" beneficial" action" of" alternatively" activated" immune" cells" that" certainly"
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(a)" Coordinates" for" stereotaxic" injections" of" LV" at" the" level" of" the" splenium" of" the" CC." A"
representative"direct" immunofluorescence"image"of"blue"fluorescent"protein"(BFP)"LV"injected"mice"
indicates"stable"expression"of"the"transgene"in"the"splenium"up"to"four"weeks"post"LV=injection."(b)*











intense" contrast" can" be" visualized" at" the" level" of" the" splenium" after" cuprizone" administration,"
reflecting" inflammation" and/or" demyelination," but" not" for" mice" that" also" received" the" IL=13" LV"
injection"(white"arrows"indicate"the"location"of"the"CC"of"cuprizone"treated"mice)."Scale"bar"="1"mm."
(c)"In"a"similar"manner,"panel"shows"a"representative"color=coded"MTR"image"for"each"experimental"
group"at" the" level"of" the" splenium"of" the"CC."Disappearance"of" the"CC" (color=coded" in" red)" can"be"
observed" after" cuprizone" administration," indicating" inflammation" and" demyelination," but" not" for"












Figure* 3:* LV* mediated* expression* of* IL713* in* the* splenium* prevents* cuprizone7induced*
inflammation,*oligodendrocyte*death*and*demyelination.""
Histological" analyses" performed" at" the" level" of" the" splenium" for" CC1+" oligodendrocytes," MBP"
myelination,"F4/80+"activated"microglia/macrophages"and"GFAP+"astrogliosis"are"depicted"in"panels"a,"
b," c" and" d," respectively," and" confirm" decreased" oligodendrocyte" cell" loss" and" demyelination"
associated"with"a"decreased"microgliosis"and"astrogliosis"in"IL=13"LV"injected"cuprizone"treated"mice."
*P<0.05," **P<0.01," ***P<0.001," One=way" ANOVA" and" Tukey" post" hoc" test" (n" =" 3" =" 6"mice)." All" p=
values" –"whether"or"not" significant" =" are" indicated" in" the" Supplementary" Tables" S4," S5," S6" and" S7."
Scale"bar"="100"μm.""
*
Figure* 4:* LV* mediated* expression* of* IL713* in* the* splenium* protects* locally* against* cuprizone7
induced*inflammation,*oligodendrocyte*death*and*demyelination."
Panel" a" shows" a" representative" T2" map" for" each" experimental" group" at" the" level" of" the" external"









with" red)" can" be" visualized" in" groups" that" received" the" cuprizone" supplemented" diet," reflecting"
inflammation"and/or"demyelination."Scale"bar"="1"mm."MTR"of" individual"mice"are"displayed" in"the"
graph" with" mean" ±" SD" and" indicated" a" decrease" of" MTR" in" all" cuprizone" treated" mice." *P<0.05,"
***P<0.001,"Linear"regression"model,"Tukey"post"hoc"test."(n"="5=11"mice)."All"p=values"–"whether"or"
not"significant"="are"indicated"in"the"Supplementary"Table"S9."Histological"analyses"performed"at"the"
level" of" the" external" capsule" for" CC1+" oligodendrocytes," MBP" myelination," F4/80+" activated"
microglia/macrophages"and"GFAP+"astrogliosis"are"depicted"in"panels"c,"d,"e"and"f,"respectively,"and"








of"each"experimental" group" stained" for" F4/80" (red)"and"MHC=II" (green)." Scale"bar"=100"μm."Graph"
displays"MHCII" staining" expressed" as" percentage" relative" of" F4/80+" cells" of" non=injected" cuprizone"
treated"mice"±"SEM."Downward"error"bars"for"white"coded"bars."Upward"error"bars"for"black"coded"
bars." Significant"appearance"of"MHCII" expression" is" indicated"by" the"*" sign."**P<0.01,"***P<0.001,"
One" sample" t=test" (n=" 3=6" mice)." All" p=values" –" whether" or" not" significant" =" are" indicated" in"
Supplementary"Table"S10." (b)"Representative" images"of"each"experimental"group"stained" for"F4/80"
(red)"and"Arg=1" (green)."Scale"bar"=100"μm."Graph"displays"Arg=1"staining"expressed"as"percentage"
relative"of"F4/80+"cells"of"non=injected"cuprizone"treated"mice"±"SEM."Downward"error"bars"for"white"
coded"bars."Upward" error" bars" for" black" coded"bars." Significant" appearance"of"Arg=1" expression" is"
indicated" by" the" #" sign." #P<0.05," One" sample" t=test" (n=" 3=6" mice)." All" p=values" –" whether" or" not"
39"
"
significant" =" are" indicated" in" Supplementary" Table" S11." (c)" Representative" images" of" each"
experimental"group"stained"for"Arg=1"(red)"and"MHCII"(green)."Scale"bar"=100"μm."Graph"shows"the"

















(a)" eGFP+" bone" marrow" chimeric" mice" were" generated" in" order" to" differentiate" infiltrating"
macrophages"(green)"from"brain=resident"microglia."At"eight"week"of"age"mice"received"an"injection"
of"BFP"LV,"IL=13"LV"or"no"injection"(No"inj.)"and"were"fed"a"cuprizone"diet"for"a"period"of"four"weeks"
to" induce" inflammation" and" demyelination." (b)" Representative" T2=weighted" images" show" hyper=
intense" contrast" at" the" level" of" the" splenium" of" the" CC" indicative" of" neuro=inflammation" and"
demyelination"following"four"weeks"of"cuprizone"diet,"but"not"in"the"case"of"mice"that"also"received"
the" IL=13" LV" injection" (Arrow" indicates" the" site" of" injection" of" IL=13" LV" and" associated" protection"
40"
"
against" cuprizone)." (c)"Representative" images"of" each"experimental" group" stained" for"MHCII" (blue)"
and"Arg=1"(red)."Scale"bar"="100"μm."(d)"Graph"shows"the"mean"density"±"RMSD"(root"mean"square"








Figure* 8:* Therapeutic* LV* mediated* expression* of* IL713* in* the* splenium* protects* against* severe*
cuprizone7induced* demyelination* and* is* associated* with* an* altered* microglia/macrophage*
phenotype.*
(a)" Eight" week" old" mice" were" assigned" to" a" control" or" cuprizone" treated" group." In" order" to" test"
whether" IL=13" LV" injection" may" exert" its" protective" effect" during" cuprizone=induced" CNS" neuro=
inflammation"and"demyelination,"a"subgroup"of"mice"that"received"the"cuprizone"diet"for"a"period"of"
2.5"weeks"were" injected"with"the" IL=13"LV."Magnetic"resonance" imaging"evaluation"and"histological"
analysis"were"performed"after"4"weeks"of"cuprizone"administration." (b)"Representative"T2"map"and"
color=coded"MTR"are"shown"for"each"experimental"group"at"the"level"of"the"splenium"of"the"CC."Mice"




FDR" corrected" (n" =" 5=15" mice)." All" p=values" –" whether" or" not" significant" =" are" indicated" in"
Supplementary" Table" S16." (d)"MTR" of" individuals" are" displayed" in" the" graph"with"mean" ±" SD" and"




–" whether" or" not" significant" =" are" indicated" in" Supplementary" Table" S16." (e)" Representative"
fluorescence"images"for"oligodendrocytes"(CC1,"red)"and"myelin"(MBP,"red)"confirm"the"preservation"
of"myelin"in"mice"that"received"the"IL=13"LV"injection"after"2.5"weeks"of"cuprizone"diet."Importantly,"
the"presence"of"Arg=1+"and"MHCII+"cells"at"the"site"of" IL=13LV" injection"was"also"verified"(Arg=1,"red"
and"MHCII,"red),"(n"="3"mice"analyzed"per"group)."Scale"bar"="100"μm."
"











